Proteome Sciences PLC ("the Company")
Notifiable Interest
A form TR-1 containing the following information has been received by the
Company.
TR-1 notification of major interests in shares
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:
Proteome Sciences Plc
2. Reason for the notification
An acquisition or disposal of voting rights
3. Full name of person(s) subject to the notification obligation:
Deutsche Bank AG
4. Full name of shareholder(s) (if different from 3):
5. Date of the transaction (and date on which the threshold is crossed or
reached if different):
11th March 2008
6. Date on which issuer notified:
12th March 2008
7. Threshold(s) that is/are crossed or reached:
3%
8. Notified details:
A: Voting rights attached to shares
Class/type Situation previous to Resulting situation after the triggering
of shares Triggering transaction
transaction
if possible Notification required under DTR transitional
using ISIN provision 7
CODE
Number Number of Number of Number of voting % of voting
of Voting shares rights rights
Shares Rights
Direct Direct Indirect Direct Indirect
GB0003104196 N/A N/A 4,028,635 4,028,635 3.06%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting rights that may % of
financial date Conversion be acquired if the instrument is voting
instrument Period/ Date exercised/ converted rights
Total (A+B)
Number of voting rights % of voting rights
4,028,635 3.06%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
10. Name of the Proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: David Lindsay / Andrew Anderson
15. Contact telephone number: +44 207 545 8533 / 8532
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.